Unsafe Sexual Behavior among HIV Positive Men Who Have Sex with Men Is Associated with New Acquisition of HCV Infection

The primary transmission routes of HCV infection are injection drug use (IDU) with needle sharing, occupational exposure in health care workers, contaminated blood products, transplants, use of medical and paramedical devices, and vertical transmission. Whether and how frequently hepatitis C virus is transmitted through sexual intercourse is a controversial and at times contentious issue.

Of note, the published literature gives significantly more weight to the notion that sexual transmission of HCV does indeed occur among gay men through unprotected anal intercourse, while it tends to minimize the risk for transmission of HCV through unprotected vaginal intercourse among heterosexuals.

Data on the issue of HCV transmission through unsafe sex among HIV positive men who have sex with men in the Swiss HIV Cohort Study is reported in the August 1, 2005 issue of Clinical Infectious Diseases [1]. Following is a summary of these data and selected excerpts from the published study:

Data on the incidence of hepatitis C virus (HCV) infection among HIV–infected persons are sparse.

Researchers of the Swiss HIV Study Cohort (SHCS) assessed the prevalence and incidence of HCV infection in the Swiss HIV Cohort Study between 1988 and 2004. They investigated the association of HCV seroconversion with mode of HIV acquisition, sex, injection drug use (IDU), and consistency of condom use. Data on condom use or unsafe sexual behavior were prospectively collected between 2000 and 2004.

Results

· The overall seroprevalence of HCV infection was 33% among a total of 7899 eligible participants and 90% among persons reporting IDU.

· 04 HCV seroconversions among 3327 participants were seen during a total follow-up time of 16,305 person-years, corresponding to an incidence of 0.64 cases per 100 person-years.

· The incidence among participants with a history of IDU was 7.4 cases per 100 person-years, compared with 0.23 cases per 100 person-years in patients without such a history (P < .001).

· In men who had sex with men (MSM) without a history of IDU who reported unsafe sex, the incidence was 0.7 cases per 100 person-years, compared with 0.2 cases per 100 person-years in those not reporting unsafe sex (P = .02).

·  The hazard of acquiring HCV infection was elevated among younger participants who were MSM.

Commentary

These results reflect continuing HCV infection in a nationwide cohort of adult persons with HIV infection in Switzerland. HCV incidence is highest in persons with a history of IDU. HCV infections occur also in persons without reported IDU, although at an incidence rate 30 times lower. Intriguingly, HCV infection is associated with inconsistent condom use in MSM in this large cohort [emphasis added—Ed]

 HCV infections in serodiscordant couples are rarely observed, at least not in heterosexual couples. Many experts therefore conclude that sexual transmission of HCV is of little importance. Nevertheless, concurrent genital ulcers caused by genital herpes simplex or syphilis might facilitate transmission of HCV if condoms are not consistently used.

In some studies, HCV prevalence was associated with increased numbers of sexual partners and intercourses, especially among MSM ; others, however, could not find such an association. These contradictory results can be explained by differences in study design, because most studies were cross-sectional analyses.

Although the findings were based on a small number of seroconversions, the researchers found a statistically significant association between reporting unsafe sex and HCV infection among MSM in recent years. They conclude that inconsistent condom use bears a small but significant risk for HCV infection in unprotected male homosexual contacts.

Of note, there are recent reports of small epidemics of HCV infection in the gay community [2]. The researchers observed a significant trend towards an increased risk of HCV seroconversion in younger MSM. If HCV is sexually transmissible, this finding is in concordance with a recent report about a lower adherence to safer sex in younger participants in the SHCS and with the higher proportion of younger MSM participants in this analysis reporting unsafe sex.

The association between serological test results positive for syphilis and the incidence of HCV infection in the MSM population further points towards possible sexual transmission of HCV infection.

With regard to heterosexual relationships without consistent condom use, these study data do not show a statistically significant increased risk of HCV infection; however, the point estimate of the hazard ratio for unsafe sex was 3.0. This clearly does not allow one to exclude such a risk.

This is the first study to report an association of unsafe sex with an increased incidence of HCV infection in HIV-infected MSM that was determined on the basis of prospective longitudinal cohort data that included regular HCV testing and reports about condom use and IDU.

In conclusion, the authors write, “Data of the large, prospective SHCS indicate that unsafe sexual behavior among MSM is associated with new acquisition of HCV infection and that HCV seroconversion continues to occur among IDU, even though needle exchange programs are available in Switzerland.”

“Thus, physicians caring for HIV-infected persons need to emphasize the prevention of HCV infection among their patients with continuing IDU and motivate MSM to practice safe sex because of the additional risk of transmitting and acquiring HCV infection.”

Division of Infectious Diseases, University Hospital Berne, Data Center Swiss HIV Cohort Study, Lausanne, Division of Infectious Diseases, University Hospital Zurich, Division of Infectious Diseases, University Hospital Geneva, Division of Infectious Diseases, University Hospital Lausanne, Basel Institute for Clinical Epidemiology, University Hospital Basel, Division of Infectious Diseases, Kantonsspital St. Gallen, and Division of Infectious Diseases, Ospedale Civico Lugano, Switzerland.

07/13/05

References

1. A Rauch and others (the Swiss HIV Cohort Study). Unsafe Sex and Increased Incidence of Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men: The Swiss HIV Cohort Study. Clinical Infectious Diseases 41(2): 395-402. August 1, 2005.

2. R Browne and others. Increased numbers of acute hepatitis C infections in HIV-positive homosexual men: is sexual transmission feeding the increase? Sexually Transmitted Infections 80: 326-327. 2004.

 



All HCV Topics
 [ A to Z ]


2-log Drop
Acute (Primary) HCV Infection
Age
Alcohol / Smoking / Diabetes
ALT
Anemia
Children
Chronic HCV Infection
Cirrhosis
Cognitive Behavioral Therapy
Complementary Therapies (CAM)
Combination Treatment
Cryoglobulinemia / Cryoglobulin
Disease Progression
Decompensation
Developing Countries
Depression
Diabetes Mellitus
Dosing
Drug Abuse
Drug Pricing

Drug Related Adverse Events
Early Treatment Cessation
Early Virologic Response

Epidemiology / African Americans
Epoetin Alpha
Early Viral Response (EVR)
Eradication
Extrahepatic Events
Experimental Treatment
Experimental Therapy (procedure)
Fibrosis
Gender
Genetics
Genotype 1 and 4
Genotype 2 and 3
Genotype 5 and 6
GGT Levels
Glucose Intolerance
Growth Factors
Guidelines

HCV Clearance
HCV Disease Progression
HCV-Drug Related Adverse Events
HCV Recurrence After Transplantation
Hearing
Hematological Growth Factors
Hemodialysis
Hemoglobin
Hemophilia
Hepatic Decompensation
Hepatic Failure
Hematological Disorders
Hepatocellular Carcinoma
Histology

Hormone Therapies
hyaluronate (HA)
Immunoglobulins
Immunosuppression
Induction Therapy
Injection Drug Use
Infergen
Insulin Resistance
Interferon
Interferon Resistance
Intron A
Kidney Disorders
Kidney Transplant

Liver Biopsy
Liver Enzymes
Liver Issues
Living Donors
Liver Stiffness Measurement (LSM)
Maintenance Therapy
Methadone
Miscellaneous
Mortality and Morbidity

Monotherapy Treatment

Mother to Child Transmission of HCV
Natural History
Neutropenia
Non-Alcoholic Fatty Liver
  Disease (NAFLD)

Non-Hepatic Cancers
Non-Hodgkins Lymphoma
Non-organ Specific Autoantibodies
Nonresponders / Relapsers
Obesity
Occult HBV Infection
Pathogenesis

Pegasys
PEG-Intron
Pegylated Inferferon
Pharmacokinetics
Platelets
Pregnancy
Productivity
PIIINP/MMP-1, prothrombin time (PT)
Quality of Life
Quasispecies
Rapid Virologic Response (RVR)
Recurrent HCV
Re-Treatment
Retinopathy
Ribavirin
Ribavirin Dosing
Risk Factors for HCC
Risk Factors
Roferon
Seroconversion
Sex (gender)
Sexual Transmission
Skin Reactions / Diseases
Sleeplessness
Steatosis
Steroids
Superinfection
Survival
Sustained Viral Response
Toxicities and Side Events
Transmission

Transplantation
Undetectable HCV RNA
Viral Eradication
Viral Kinetics
Viral Load
Weight-based Dosing
Women and Children

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HIV AND AIDS
| HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH
|
TESTS | INTERNET CONFERENCE REPORTS | LINKS | ABOUT US | CONTACT US